GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
HALOZYME THERAPEUTIC (HALO) [hlAlert]

Rating:
Outperform
HALO
up 117.87 %

HALOZYME THERAPEUTIC (HALO) rated Outperform by William Blair

Posted on: Thursday,  Apr 8, 2010  8:25 AM ET by William Blair

William Blair rated Outperform HALOZYME THERAPEUTIC (NASDAQ: HALO) on 04/08/2010, when the stock price was $8.28. Since
then, HALOZYME THERAPEUTIC has gained 117.87% as of 08/27/2015's recent price of $18.04.
If you would have followed this William Blair's recommendation on HALO, you would have gained 117.87% of your investment in 1967 days.

Halozyme Therapeutics, Inc. (Halozyme) is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix (Matrix) for the endocrinology, oncology, dermatology and drug delivery markets The Company's products are based on the property covering the family of human enzymes known as hyaluronidases. The Company has two marketed products: HYLENEX, a product used as an adjuvant to increase the absorption and dispersion of other injected drugs and fluids, and Cumulase, a product used for in vitro fertilization (IVF). The Company has partnerships with F. Hoffmann-La Roche, Ltd and Hoffmann-La Roche, Inc. (Roche), to apply Enhanze Technology to Roche?s biological therapeutic compounds for up to 13 targets, and with Baxter Healthcare Corporation (Baxter), to apply Enhanze Technology to Baxter?s biological therapeutic compound, GAMMAGARD LIQUID.

The Equity Research department provides the firm's clients with in-depth investment analysis and investment recommendations. Acting as the company's laboratory for new investment ideas, it specializes in providing investment analysis on quality growth companies. Located together in our Chicago office, our equity analysts currently follow a universe of nearly 360 companies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/8/2010 8:25 AM Buy
None
8.28
as of 12/31/2010
1 Week down  -8.38 %
1 Month up  2.30 %
3 Months down  -7.91 %
1 YTD down  -14.25 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy